haloperidol has been researched along with Cancer of Ovary in 3 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The patient was treated over a period of 48 days with a morphine dosage ranging from 10 to 60 mg/h, which kept her free of pain." | 1.28 | [Continuous ambulatory intravenous morphine infusion for pain therapy in advanced ovarian cancer]. ( Günter, HH; Hilfrich, J; Kühnle, H; Schönborn, I; Sorge, J; Steffmann, B, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Back, I | 1 |
| Taubert, M | 1 |
| Sorge, J | 1 |
| Schönborn, I | 1 |
| Günter, HH | 1 |
| Steffmann, B | 1 |
| Hilfrich, J | 1 |
| Kühnle, H | 1 |
| Devès, G | 1 |
| Ortega, R | 1 |
3 other studies available for haloperidol and Cancer of Ovary
| Article | Year |
|---|---|
Akathisia and an unusual symptomatic treatment: a case report.
Topics: Akathisia, Drug-Induced; Cyclizine; Exercise Therapy; Female; Fluoxetine; Haloperidol; Humans; Metho | 2007 |
[Continuous ambulatory intravenous morphine infusion for pain therapy in advanced ovarian cancer].
Topics: Diazepam; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; | 1992 |
Subcellular mass determination by 4He+ energy-loss micro-spectrometry.
Topics: Adenocarcinoma; Epoxy Resins; Female; Helium; Humans; Microscopy, Electron, Scanning Transmission; O | 2002 |